Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew B Ward

Showing results (181-190 of 493) with videos related to

Pageof 50
Sort By:
Cell Reports|October 7, 2020
An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding DomainNicholas C Wu, Meng Yuan, Hejun Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2013
Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformationRajesh P Ringe, Rogier W Sanders, Anila Yasmeen, et al.
Communications Biology|May 15, 2023
Structural insights into the broad protection against H1 influenza viruses by a computationally optimized hemagglutinin vaccineJohn V Dzimianski, Julianna Han, Giuseppe A Sautto, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2020
An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domainNicholas C Wu, Meng Yuan, Hejun Liu, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
Structural Mapping of Polyclonal IgG Responses to HA After Influenza Virus Vaccination or InfectionAndré Nicolás León, Alesandra J Rodriguez, Sara T Richey, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2013
Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9Jean-Philippe Julien, Jeong Hyun Lee, Albert Cupo, et al.
Nature Communications|January 23, 2026
An H5N1 clade 2.3.4.4b virus vaccine that elicits cross-protective antibodies against conserved domains of H5 and N1 glycoproteinsEduard Puente-Massaguer, Thales Galdino Andrade, Michael J Scherm, et al.
Journal of Pharmaceutical Sciences|February 19, 2019
Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine AntigensNeal Whitaker, John M Hickey, Kawaljit Kaur, et al.
Frontiers in Immunology|July 3, 2020
Harnessing Activin A Adjuvanticity to Promote Antibody Responses to BG505 HIV Envelope TrimersDiane G Carnathan, Kirti Kaushik, Ali H Ellebedy, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
A clade 2.3.4.4b H5N1 virus vaccine that elicits cross-protective antibodies against conserved domains of H5 and N1 glycoproteinsEduard Puente-Massaguer, Thales Galdino Andrade, Michael J Scherm, et al.
Pageof 50

Showing results (181-190 of 493) with videos related to

Sort By:
Pageof 50
Cell Reports|October 7, 2020
An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding DomainNicholas C Wu, Meng Yuan, Hejun Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2013
Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformationRajesh P Ringe, Rogier W Sanders, Anila Yasmeen, et al.
Communications Biology|May 15, 2023
Structural insights into the broad protection against H1 influenza viruses by a computationally optimized hemagglutinin vaccineJohn V Dzimianski, Julianna Han, Giuseppe A Sautto, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2020
An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domainNicholas C Wu, Meng Yuan, Hejun Liu, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
Structural Mapping of Polyclonal IgG Responses to HA After Influenza Virus Vaccination or InfectionAndré Nicolás León, Alesandra J Rodriguez, Sara T Richey, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2013
Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9Jean-Philippe Julien, Jeong Hyun Lee, Albert Cupo, et al.
Nature Communications|January 23, 2026
An H5N1 clade 2.3.4.4b virus vaccine that elicits cross-protective antibodies against conserved domains of H5 and N1 glycoproteinsEduard Puente-Massaguer, Thales Galdino Andrade, Michael J Scherm, et al.
Journal of Pharmaceutical Sciences|February 19, 2019
Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine AntigensNeal Whitaker, John M Hickey, Kawaljit Kaur, et al.
Frontiers in Immunology|July 3, 2020
Harnessing Activin A Adjuvanticity to Promote Antibody Responses to BG505 HIV Envelope TrimersDiane G Carnathan, Kirti Kaushik, Ali H Ellebedy, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
A clade 2.3.4.4b H5N1 virus vaccine that elicits cross-protective antibodies against conserved domains of H5 and N1 glycoproteinsEduard Puente-Massaguer, Thales Galdino Andrade, Michael J Scherm, et al.
Pageof 50